Skip to main content

Table 3 Subgroup analysis of prostate cancer detection rate according to DRE and imaging findings in the different ranges of PSA levels

From: Detection rate of prostate cancer following biopsy among the northern Han Chinese population: a single-center retrospective study of 1022 cases

PSA (ng/ml) Prostate cancer detection rate (%) (no./total no.)
Negative DRE Positive DRE Negative imaging Positive imaging
0–4 29.7 (19/64) 33.3 (2/6) 27.5 (11/40) 66.7 (20/30)
4–10 13.5 (29/215) 58.2 (32/55) 11.2 (21/187) 48.2 (40/83)
10–20 25.6 (61/238) 59.6 (62/104) 25.7 (54/210) 52.3 (69/132)
20–100 55.6 (70/126) 62.8 (76/121) 54.4 (43/79) 61.3 (103/168)
≥ 100 0 (0/3) 96.7 (87/90) 0 (0/0) 100.0 (93/93)
Overall 27.7 (179/646) 68.9 (259/376) 25.0 (129/516) 64.2 (325/506)
  1. DRE digital rectal examination, PSA prostatic-specific antigen